BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin AW, Wong KH. Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong Kong. J Hepatol 2013;59:1363-4. [PMID: 23994385 DOI: 10.1016/j.jhep.2013.08.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 El Hachimi H, El Alem MMM, Haimoudane E, Yebouk C, Pedersen J, Fall-malick F, Khiddi F, Abdawe M, Sadegh SA, Fausther-bovendo H, Mohamed Abdellahi MV. The First Assessments of Pediatric HBV Immunization Coverage in Mauritania and Persistence of Antibody Titers Post Infant Immunizations. Vaccines 2023;11:588. [DOI: 10.3390/vaccines11030588] [Reference Citation Analysis]
2 Wong NS, Chan DPC, Poon CM, Chan CP, Lau LHW, Yeoh EK, Lee SS. Hepatitis B burden and population immunity in a high endemicity city - a geographically random household epidemiology study for evaluating achievability of elimination. Epidemiol Infect 2023;151:e22. [PMID: 36628568 DOI: 10.1017/S095026882300002X] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Papadopoulos N, Gkavogiannakis N, Panagakou S, Papadatos G, Panagoulis E, Deutsch M, Liaskonis K, German V. Prevalence of Hepatitis B Serum Markers in Young Military Recruits in Greece: A Comparison Study between 2005 and 2019 Cohorts. Livers 2021;1:230-5. [DOI: 10.3390/livers1040018] [Reference Citation Analysis]
4 Qama A, Allard N, Cowie B, Davis JS, Davies J. Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition. Intern Med J 2021;51:910-22. [PMID: 32975893 DOI: 10.1111/imj.15069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li J, Meng F, Zheng J, Liang Q, Li H, Li J, Zhang L, Gan J, Zhu F. Immune persistence induced by three doses of 60 μg hepatitis B vaccine in non-responders following standard primary vaccination in Chinese adults. Hum Vaccin Immunother 2021;17:2762-7. [PMID: 33735590 DOI: 10.1080/21645515.2021.1877079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wong RJ, Gish RG, Cheung R, Chitnis AS. Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease. Am J Med 2021;134:882-92. [PMID: 33775642 DOI: 10.1016/j.amjmed.2021.02.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Le MH, Yeo YH, So S, Gane E, Cheung RC, Nguyen MH. Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016. JAMA Netw Open 2020;3:e2022388. [PMID: 33175174 DOI: 10.1001/jamanetworkopen.2020.22388] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
8 Miao N, Zheng H, Sun X, Zhang G, Wang F. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China. Sci Rep 2020;10:18155. [PMID: 33097788 DOI: 10.1038/s41598-020-75338-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Ma JC, Wu ZW, Zhou HS, Gao Z, Hao ZY, Jin F, Zhang YH, Li MJ, Wang F, Li Q, Bi SL, Zhao YL. Long-term protection at 20-31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community. Hum Vaccin Immunother 2020;16:16-20. [PMID: 31339432 DOI: 10.1080/21645515.2019.1646575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
10 Norizuki M, Kitamura T, Komada K, Sugiyama M, Mizokami M, Xeuatvongsa A, Som-Oulay V, Vongphrachanh P, Machida M, Wada K, Ishii K, Kiyohara T, Wakita T, Hachiya M. Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People's Democratic Republic. BMC Infect Dis 2019;19:507. [PMID: 31182043 DOI: 10.1186/s12879-019-4086-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
11 Das S, Ramakrishnan K, Behera SK, Ganesapandian M, Xavier AS, Selvarajan S. Hepatitis B Vaccine and Immunoglobulin: Key Concepts. J Clin Transl Hepatol 2019;7:165-71. [PMID: 31293917 DOI: 10.14218/JCTH.2018.00037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
12 Khantimirova LM, Kozlova TY, Postnova EL, Shevtsov VA, Rukavishnikov AV. Retrospective Analysis of Viral Hepatitis B Incidence in Russia from 2013 to 2017 in the Context of Preventive Vaccination. Biopreparaty Profilaktika, diagnostika, lechenie 2018;18:225-235. [DOI: 10.30895/2221-996x-2018-18-4-225-235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Zhao H, Zhou YH. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no? Hum Vaccin Immunother 2018;14:456-63. [PMID: 29083945 DOI: 10.1080/21645515.2017.1397243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
14 Zhou YH. Be cautious for exceptional results in evaluating the effect of adolescent booster of hepatitis B vaccine. Int J Infect Dis 2018;66:150-2. [PMID: 29138014 DOI: 10.1016/j.ijid.2017.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Chan MCW, Cheng FWT, Sze KH, Wong AH, Leung AWK, Chan PKS, Li CK. Hepatitis B infection acquired after haematopioetic stem cell transplant through horizontal mode. J Med Virol 2017;89:1882-4. [PMID: 28460154 DOI: 10.1002/jmv.24835] [Reference Citation Analysis]
16 Wang ZZ, Gao YH, Lu W, Jin CD, Zeng Y, Yan L, Ding F, Li T, Liu XE, Zhuang H. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Hum Vaccin Immunother 2017;13:909-15. [PMID: 27874311 DOI: 10.1080/21645515.2016.1250990] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
17 Simons BC, Spradling PR, Bruden DJ, Zanis C, Case S, Choromanski TL, Apodaca M, Brogdon HD, Dwyer G, Snowball M, Negus S, Bruce MG, Morishima C, Knall C, McMahon BJ. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen. J Infect Dis. 2016;214:273-280. [PMID: 27056956 DOI: 10.1093/infdis/jiw142] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
18 Lin AW, Wong KH. Surveillance and response of hepatitis B virus in Hong Kong Special Administrative Region, 1988-2014. Western Pac Surveill Response J 2016;7:24-8. [PMID: 27757251 DOI: 10.5365/WPSAR.2015.6.3.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gara N, Abdalla A, Rivera E, Zhao X, Werner JM, Liang TJ, Hoofnagle JH, Rehermann B, Ghany MG. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. Clin Infect Dis. 2015;60:505-513. [PMID: 25389254 DOI: 10.1093/cid/ciu867] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]